Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

SenseTime MedTech raises over $100M in Series B funding led by Lianchuang Capital and CECC Digital Finance Fund to advance AI-powered medical technology.

PRIVATESep 24, 2026•about 2 hours ago

Amount Raised

$100 Million

Round Type

Series B

ShanghaiBiotechnologyHealth CareArtificial IntelligenceMedicalMedical Device

Investors

Lianmei GroupCecc Digital Finance FundLianchuang Capital

Description

Shanghai SenseTime Shancui Medical Technology Co., Ltd. (SenseTime MedTech) completed a Series B financing round of over $100 million in early August 2026. The round was led by Lianchuang Capital, CECC Digital Finance Fund, Lianmei Group, and several insurance capital investors. This funding follows the company's Series A round completed just months earlier

Company Information

Company

SenseTime MedTech

Location

Shanghai, China

About

SenseTime MedTech is a Shanghai-based AI healthcare company spun off from SenseTime Technology in 2022, specializing in medical large models and intelligent agent operating systems. Its flagship product is a 'medical world model' featuring the self-developed large model 'Da Yi' that coordinates specialized sub-models for medical image reading, pathological analysis, and endoscopic operations. The company has deployed its solutions across hundreds of hospitals in China and internationally, serving over 10 million patients. It recently completed Series B financing of over $100 million and is preparing for IPO with a valuation exceeding 10 billion yuan.

Fundz sees it the moment SenseTime MedTech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for SenseTime MedTech's next move

See what Strategic adds

Funding Insights

Based on industry data
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

SenseTime MedTech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.